Search results for "Cancer screening"
Cervical cancer screening may be able to occur later, less often in HPV-vaccinated women, study suggests
When compared with no intervention, vaccination alone with no screening produced a 64.6% mean reduction in lifetime cervical cancer risk, and screening strategies increased this risk reduction to a range of 88% to 98%. The lowest cost-effectiveness ratio was seen with cytology-only screening every 5 years starting at age 35, compared with vaccination alone.
https://immattersacp.org/weekly/archives/2016/10/25/4.htm
25 Oct 2016
Earn trust, counter misinformation
Physicians are on the front lines of addressing medical misinformation, increasingly figuring out what to address and how.
https://immattersacp.org/archives/2023/06/earn-trust-counter-misinformation.htm
1 Jun 2023
USPSTF draft recommendation would expand lung cancer screening
The U.S. Preventive Services Task Force (USPSTF)'s draft recommendation changes the age range and pack-year eligibility criteria.
https://immattersacp.org/weekly/archives/2020/07/14/2.htm
14 Jul 2020
Colorectal cancer screening may be cost-effective beyond age 75 in previously unscreened patients, modeling study suggests
Colorectal cancer screening (colonoscopy, sigmoidoscopy, or fecal immunohistochemical testing) may be cost-effective for patients older than 75 who have never been previously screened, according to a new study.
https://immattersacp.org/weekly/archives/2014/06/03/1.htm
3 Jun 2014
ACS changes breast cancer screening recommendations for women at average risk
Based on the available evidence, the American Cancer Society recommends that women who are at average risk of breast cancer should have regular screening mammography beginning at age 45.
https://immattersacp.org/weekly/archives/2015/10/27/2.htm
27 Oct 2015
Potential overdiagnosis may be significantly associated with breast cancer screening
Danish researchers assessed screening programs offering biennial mammography for women ages 50 to 69 years to determine trends in the incidence of advanced and nonadvanced breast cancer tumors.
https://immattersacp.org/weekly/archives/2017/01/10/1.htm
10 Jan 2017
Home-based HPV screening appears cost-effective, study finds
In an economic evaluation of 19,851 female participants from a randomized clinical trial, incremental cost-effectiveness ratios for increased uptake of human papillomavirus (HPV) screening ranged from $86 to $146 per additional screening completed.
https://immattersacp.org/weekly/archives/2023/03/28/4.htm
28 Mar 2023
Personal risk-based screening for lung cancer may be more cost-effective than recommended cutoffs
While risk-based screening strategies were robustly more cost-effective than the 2021 U.S. Preventive Services Task Force recommendation in a modeling study, whether the results will be replicable in complex real-world clinical practice remains uncertain, an editorial noted.
https://immattersacp.org/weekly/archives/2023/02/07/5.htm
7 Feb 2023
Physicians self-report overuse of ovarian cancer screening while recommended cancer screening remains underused
Many physicians report screening low- and medium-risk women for ovarian cancer despite evidence-based guidelines recommending against routine screening, a new study found.
https://immattersacp.org/weekly/archives/2012/02/07/1.htm
7 Feb 2012
Discuss options with patients to increase colorectal cancer screening rates
Yul Ejnes, MD, MACP, continues his monthly column at KevinMD.com, discussing how physicians can increase screening rates for the second leading cause of cancer-related deaths in the U.S.
https://immattersacp.org/weekly/archives/2013/12/17/6.htm
17 Dec 2013